NCT04087876 2025-04-06
Expanded Access Use of Derazantinib for Advanced Intrahepatic Cholangiocarcinoma (iCCA) With FGFR Genomic Alterations
Basilea Pharmaceutica
No longer available
Basilea Pharmaceutica
University of California, Irvine
H. Lee Moffitt Cancer Center and Research Institute
City of Hope Medical Center
Delcath Systems Inc.